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Background
Secondary osteoporosis due to chronic disease is a
major pediatric health concern and has certain unique
diagnostic with various clinical challenges. Bisphospho-
nates has been used in small numbers of pediatric
patients to treat secondary osteoporosis resulted in sig-
nificantly fewer fractures and improved mobility.
Objective
To present case series of secondary osteoporosis due to
chronic disease treated with biphosphonate.
Case Series
We included 6 patients (2 boys, 4 girls), 7–15 years of
age with secondary osteoporosis who were treated with
biphosphonate. Two patients were diagnosed acute lym-
phoblastic leukemia, two patients with systemic lupus
erythematosus and others with juvenile rheumatoid
arthritis. Two patients received methotrexate and dexa-
methasone; one patient was treated with methotrexate
and prednisone; two patients with methylprednisolone;
and rest with only methotrexate. Four of them suffered
back pain due to trauma and from radiographic exami-
nation showed multiple compression fracture on the
vertebrae. Lumbal BMD Z-score was ranging from -2.8
to -5.1 in patients who had fracture, while in patients
without fracture -2.6 to -3.1. We used zoledronic acid
0.05 mg/kgBW. Two patients already received pamidro-
nate as previous treatment. In 6 - 12 months of follow-
up, there were evidence of reduced pain, improved
mobility and BMD Z-score, also no evidence of new
fractures in radiographic evaluation.
Conclusion
Bisphosphonates appears to be safe and effective as
treatment for children with secondary osteoporosis.
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